GlassScriptPhysician profile
Michael H Boothby
NPI 1669419743
$14,622.09
in general payments reported to CMS, 2019-2025
11 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,681 · 2020: $13.13 · 2021: $13.13 · 2022: $1,200 · 2023: $42.83 · 2024: $10K · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $1,104 · Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Travel and Lodging | $1,103.64 |
| Food and Beverage | $611.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shalby Advanced Technologies, INC. | $10,000.00 | 2024 | Consensus Knee System, Cks - Vitalite |
| Pylant Medical | $2,767.72 | 2019-2025 | |
| Arthrex, INC. | $1,450.36 | 2025 | |
| Abbott Laboratories | $137.59 | 2025 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2019 | |
| Steris Corporation | $42.83 | 2023 | |
| Depuy Synthes Sales INC. | $32.56 | 2019 | |
| Innovation Technologies INC | $24.65 | 2024 | Irrisept |
| Horizon Therapeutics Plc | $15.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.13 | 2021 | |
| Vericel Corporation | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boothby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.